Metabolic and histological complications in ileal urinary diversion: Challenges of tissue engineering technology to avoid them

European Review for Medical and Pharmacological Sciences

Volumn 11, Issue 4, 2007, Pages 257-264

  Alberti, C ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Ileal urinary diversion; Malignancy; Metabolism; Tissue engineering; Urology

Indexed keywords

BIOMATERIAL;

ANASTOMOSIS; ARTICLE; BLADDER RECONSTRUCTION; CYANOCOBALAMIN DEFICIENCY; HISTOPATHOLOGY; HUMAN; HYPOKALEMIA; ILEAL CONDUIT; INTESTINE TUMOR; LONG TERM CARE; METABOLIC DISORDER; MUSCLE FUNCTION; PATHOPHYSIOLOGY; SMOOTH MUSCLE; TISSUE ENGINEERING; URINARY DIVERSION; URINE; UROTHELIUM;

HUMANS; ILEUM; INTESTINAL ABSORPTION; MALABSORPTION SYNDROMES; NEOPLASMS; TISSUE ENGINEERING; TREATMENT OUTCOME; URINARY BLADDER; URINARY DIVERSION; URINARY RESERVOIRS, CONTINENT;

EID: 34748835343     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. CRUZ DN, HUOT SJ. Metabolic complications of urinary diversion. Am J Med 1997; 102: 477-484.
2. THOMAS DJ, GOBLE NM, GILLAT DA, HAMMONDS JC, SMITH PJB. Histological and environmental changes in long-stanting ileal conduit. J Roy Soc Med 1990; 83: 557-563.
3. ATAL A, BAUER SB, SOKER S, YOO JJ, RETIK AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006; 367: 1241-1246.
4. CHUNG SY. Bladder tissue-engineering: A new practical solution? Lancet 2006; 367: 1215-1216.
5. MALONE MJ, IZES JK, HURLEY U. Carcinogenesis: The fate of intestinal segments used in urinary reconstruction. Urol Clin North Am 1997; 24: 723-728.
6. FILMER RB, SPENCER JR. Malignancies in bladder augmentations and intestinal conduits. J Urol 1990; 143: 671-678.
7. DI TONNO F, CASSARO M, BERTOLDIN R, VIANELLO F, DI PIETRO R, LAVELLI D, RUGGE M. Colonic metaplasia in the long-term follow-up of the ileal neobladder. Eur Urol 2001; 39: 15-18.
8. SENKUL T, YILDIRIM S, ISERI C, KARADEMIR K, ERDEN D, BAYKAL K. Histopathologic changes in the mucosa of ileal orthotopic neobladder findings in 24 patients followed up for 5 years. Scand J Urol Nephrol 2003; 37: 202-204.
9. GSCHWEND JE. Bladder substitution. Curr Opin Urol 2003; 13: 477-482.
10. ALBERTI C, UGOLOTTI G, GABBI C. Experimental enterocystoplasty: functional assessment by Na1311 and 75Se-methionine absorption. Morphological findings in light and scanning electron microscopy. Urologia 1974; 41: 369-387.
11. HANKE P, HOFMANN M, SCHNEIDER M, BICKEBBOR R, JONAS D. Histological and scanning electron microscopic alterations in ileal conduit depending on the time factor. Eur Urol 1990; 45: 84-87.
12. HALL MC, KOCH MO, HALTER SA, DAHLSTEDT SM. Morphological and functional alterations of intestinal segments following urinary diversion. J Urol 1993; 149: 664-666.
13. SCHELZI S, FAUSSONE M, SERNI S, LAPINI A, CARINI M. Morphological modifications of the intestinal mucosa in orthotopic reservoirs. Acta Urol Ital 1995; 4: 137-140.
14. ARAGONA E DE CARO R, PARENTI A, ARTIBANI W, BASSI P, MUNARI PF, PAGANO F. Structural and ultrastructural changes in ileal neobladder mucosa: A 7-year follow-up. Br J Urol 1998; 81: 55-61.
15. ALBERTI C. From the intestinal neobladder to the bioartificial bladder: Remarks on some biological implications. Minerva Urol Nephrol 2000; 52: 219-222.
16. BISTOLFI F. Bioconductive connectional system. In: Bistolfi F, editor. Biostructures and radiations: Order disorder. Torino: Ed Minerva Medica, 1991: 53-60.
17. FICHTNER J. Follow-up after urinary diversion. Urol Int. 1999; 63: 40-45.
18. MARCHEGGIANO A, IANNONI C, LATELLA G, FRIERI G, DIOSI D, DE DOMINICIS C, LAURENTI C, CAPRILLI R. Abnormalities of colonic mucin secretion and metabolic changes after intestinal urinary diversion for bladder extrophy. A prospective study. Br J Urol 1991; 67: 477-482.
19. PARENTI A, ARAGONA F, BORTUZZO G, DE CARO R, PAGANO F. Abnormal patterns of mucin secretion in ileal neobladder mucosa: Evidence of preneoplastic lesion? Eur Urol 1999; 35: 98-101.
20. CARINI M, FAUSSONE-PELLEGRINI MS, SCHELZI S, SERNI S, LAPINI A, RIZZO M. Adaptive morphological changes of intestinal mucosa in orthotopic ileal bladder. Short-term and long-term evaluation. J Submicrosc Cytol Pathol 1996; 28: 527-536.
21. KOJIMA Y, ASAKA H, ANDO Y, TAKANASHI R, KOHRI K. Mucosal morphological changes in the ileal neobladder. Br J Urol 1998; 82: 114-117.
22. LANE T, SHAH J. Carcinoma following augmentation ileocystoplasty. Urol Int 2000; 64: 31-32.
23. GERHARZ EW, TURNER WH, KÄLBLE T, WOODHOUSE CRJ. Metabolic and functional consequences of urinary reconstruction with bowel. BJU Int 2003; 91: 143-149.
24. WOODHOUSE CRJ. The infective, metabolic and histological consequences of enterocystoplasty. Eur Urol Ser 1994; 3: 10-15.
25. SAKANO S, YOSHIHIRO S, JOKO K, KAWANO H, NAITO K. Adenocarcinoma developing in an ileal conduit. J Urol 1995; 153. 146-148,
26. KERFOOT BE STEELE GS, DATTA MW, RICHIE JP. Carcinoid tumor in an ileal conduit diversion. J Urol 1999; 162: 1685-1686.
27. FREEMAN JA, TARTER TH A, ESRIG D, STEIN JP, ELMAZIAN DA, CHEN SC, GROSHEN S, LIESKOVSKY G, SKINNER DG. Urethral recurrence in patients with orthotopic ileal neobladders. J Urol 1996; 156: 1615-1619.
28. MC DOUGAL WS. Metabolic complications of urinary intestinal diversion. J Urol 1992; 147: 1199-1208.
29. GOUGH DCS. Enterocystoplasty. BJU Int 2001; 88: 739-743.
30. RACIOPPI M, D'ADDESSI A, FANASCA A, MINGRONE G, CAPRISTO E, BENEDETTI G, ALCINI A, ALCINI E. Acid-base and electrolyte balance in urinary intestinal orthotopic reservoir: Ileocecal neobladder compared with ileal neobladder. Urology 1999; 54: 629-635.
31. GATTEGNO B, ESTRADE V. Metabolic consequences of urinary intestinal diversion. Eur Urol 1999, 36/5 (Curric Urol 3.4: 1-6).
32. PAGANO F, ARTIBANI W, LIGATO P, PIAZZA R, GARBEGLIO A, PASSERINI G. Vescica ileale padovana: A technique for total bladder replacement. Eur Urol 1990; 17: 149-157.
33. ALCINI E, D'ADDESSI A, RACIOPPI M, MENCHINELLI P, ANASTASIO G, GRASSETTI F, DESTITO A, GIUSTACCHINI M. Results of 4 years experience with bladder replacement using an ileocecal segment with multiple transverse teniamyotomies. J Urol 1993; 149: 735-738.
34. HAUTMANN RE. Urinary diversion: Ileal conduit to neobladder. J Urol 2003; 169: 834-842.
35. POULSEN AL, OVERGAARD K, STEVEN K. Bone metabolism following bladder substitution with the ileal urethral Kock reservoir. Br J Urol 1997; 79: 339-347.
36. GILBERT SM, HENSLE T. Metabolic consequences and long-term complications of enterocystoplasty in children: A review. J Urol 2005; 173: 1080-1086.
37. SIMEONE C, ZANI D, PEZZOTTI G, ZANOTELLI T, COSCIANI CUNICO S. Metabolic changes in patients with neobladder and continent urinary reservoir. Urologia 1994; 61: 229-234.
38. MEYER JP, DRAKE B, BOORER J, GILLATT D, PERSAD R, FAWCETT D. A three-centre experience of orthotopic neobladder reconstruction after radical cystectomy. BJU Int 2004; 94: 1317-1321.
39. VALENTINI G, CAPRISTO E, SCARFONE A, MINGRONE G, GRECO AV, GASBARRINI G. Main physiopathologic mechanisms involved in hepatic drug reactions. Minerva Gastroenterol Dietol 2002; 48: 81-88.
40. SINGH G, THOMAS DG. Bowel problems after enterocystoplasty. Br J Urol 1997; 79: 328-332.
41. RACIOPPI M, D'ADDESSI A, FANASCA A, MINGRONE G, BENEDETTI G, CAPRISTO E et al. Vitamin B12 and folic acid plasma levels after ileocecal and ileal neobladder reconstruction. Urology 1997; 50: 888-892.
42. FONTAINE E, LEAVER R, WOODHOUSE CRJ. The effect of intestinal urinary reservoir on renal function: A 10-year follow-up. BJU Int 2000; 86: 195-198.
43. MINERVINI A, BONI G, SAUNITRI G, MARIANI G, MINERVINI R. Evaluation of renal function and upper urinary tract morhology in ileal orthotopic neobladder with no antireflux mechanism. J Urol 2005; 173: 144-147.
44. HOHENFELLNER M, DAHMS S, PFITZENMAIER J, THUROFF JW. Orthotopic bladder augmentation and substitution. Curr Opin Urol 1999; 9: 309-314.
45. CROSS WR, THOMAS DFM, SOUTHGATE J. Tissue engineering and stem cell research in urology. BJU Int 2003; 92: 165-171.
46. RAM-LIEBIG G, MEIE A, HAKENBERG OW, HAASE M, BARETTON G, WIRTH MP. Induction of proliferation and differentiation of cultured urothelial cells on acellular biomaterials. BJU Int 2004; 94: 922-927.
47. CHENG EY, KROPP BP. Urologic tissue engineering with small intestinal submucosa: Potential clinical applications. World J Urol 2000; 18: 19-25.
48. PIECHOTA HJ, DAHMS SE, NUNES JS, DAHIYA R, LUE TF, TANAGHO EA. In vitro functional properties of the regenerated rat bladder by the bladder acellular matrix graft. J Urol 1998; 159: 1717-1724.
49. SIEVERT KD, TANAGHO EA. Organ-specific acellular matrix for reconstruction of the urinary tract. World J Urol 2000; 18: 19-25.
50. ZHANG Y, FRIMBERGER D, CHENG EY, LIN H-K, KROPP BP. Challenges in a larger bladder replacement with cell-seeded and un-seeded small intestinal submucosa grafts in a subtotal cystectomy model. BJU Int 2006; 98: 1100-1105.
51. FEIL G, CHRIST-ADLER M, MAURER S, CORVIN S, RENNEKAMPFF HO, KRUG J, HENNENLOTTER J, KUEHS U, STENZL A, SIEVERT KD. Investigations of urothelial cells on commercially available small intestine submucosa. Eur Urol 2006; 50: 1330-1337.
52. CHUNG SY, KRIVOROV NP, RAUSEI V, THOMAS L, FRANTZEN M, LANDSITTEL D, KANG YM, CHON CH, NG CS, FUCHS GJ. Bladder reconstitution with bone marrow derived stem cells seeded on SIS improves morphological and molecular composition. J Urol 2005; 174: 353-359.
53. AKBAL C, LEE SD, PACKER SC, DAVIS MM, RINK RC, KAEFER M. Bladder augmentation with acellular dermal biomatrix in a diseased animal model. J Urol 2006; 176: 1706-1711.
54. ATALA A. Tissue engineering in the genitourinary system. In: Atala A, Mooney D, eds. Tissue engineering. Boston: Birkhauser Press 1997; 149.
55. OPERPENNING F, MENG J, Yoo JJ, ATALA A. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering, Nat Biotechnol 1999; 17: 149-155.
56. LAI Y, YOON CY, YOO JJ, WULF T, ATALA A. Phenotypic and functional characterization of in vivo engineered smooth muscle from normal and pathological bladders. J Urol 2002; 168: 1853-1857.
57. ATALA A. Recent applications of regenerative medicine to urologic structures and related tissues. Curr Opin Urol 2006; 16: 305-309.
58. EBERLY D, ATALA A. Tissue engineering using adult stem cells. Methods Enzymol 2006; 420: 287-302.
59. DE COPPI P, CALLEGARI A, CHIAVEGATO A, GASPAROTTO L, PICCOLI M, TAIANI J, POZZOBON M, BOLDRIN L, OKABE M, COZZII E, ATALA A, GAMBA P, SARTORE S. Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol 2007; 177: 369-376.
60. SHIEH S-J, VACANTI JP. State-of-the-art tissue engineering: From tissue engineering to organ building. Surgery 2005; 137: 1-7.
61. KHADEMHOSSEINI A, LANGER R, BORENSTEIN J, VACANTI JP. Microscale technologies for tissue engineering and biology. Proc Nat Acad Sci USA 2006; 103: 2480-2487.
62. MACDONALD RA, LAURENZI BF, VISWANATHAN G, AJAYAN PM, STEGEMANN JP. Collagen-carbon nanotube composite materials as scaffolds in tissue engineering. J Biomed Mater Res 2005; 74A: 489-496.
63. HARRISON BS, ATALA A. Carbon nanotube applications for tissue engineering. Biomaterials 2007; 28: 344-353.